Funded Tech Companies
Zyngenia
Zyngenia is a leading biopharmaceutical company, located in Washington. Investment was provided by private investors and New Enterprise Associates.
Company Overview
Company Name
Zyngenia
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
1050 Connecticut Ave. NW 500
Washington, DC 20036
USA
Washington, DC 20036
USA
Phone
Website
Email Address
Company Background Information
Overview
At Zyngenia, we are developing the next generation of antibody-based drugs called Zybody therapeutics. We are spearheading the development of this novel class of drugs to create more potent and more broadly acting protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
9/7/2012
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Parkinson
Chief Scientific Officer
David Hilbert
Vice President
Viktor Roschke
Company Investors
- New Enterprise Associates (David Mott)
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
Our data comes from VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs